World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
128
Citations
93658
World Ranking
2644
National Ranking
1479

Overview

Sagar Lonial is affiliated with Emory University in the United States and has a significant body of research primarily focused on hematology and oncology, with an emphasis on multiple myeloma. Their work spans the intersection of medicine, molecular biology, and genetics, reflecting expertise in both basic science and clinical research.

The scientist has contributed extensively to fields of study including:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

More specifically, their subfields of study encompass:

  • Hematology
  • Molecular Biology
  • Oncology
  • Immunology
  • Genetics

The main research topics covered by their publications are:

  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • CAR-T cell therapy research
  • Peptidase Inhibition and Analysis
  • Cancer Treatment and Pharmacology
  • Chronic Lymphocytic Leukemia Research
  • Ubiquitin and proteasome pathways

Sagar Lonial has a number of recent papers notable for their publication in high-impact journals. These include:

  • "Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma," 2021, New England Journal of Medicine
  • "Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma," 2022, New England Journal of Medicine
  • "Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group," 2021, The Lancet Oncology
  • "Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial," 2020, The Lancet Oncology
  • "Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma," 2020, Journal of Clinical Oncology

Frequent collaborators in their research include:

  • Ajay K. Nooka
  • Jonathan L. Kaufman
  • Nisha S. Joseph
  • Craig C. Hofmeister
  • Madhav V. Dhodapkar

The venues where Sagar Lonial publishes most frequently are:

  • Clinical Lymphoma Myeloma & Leukemia
  • Blood
  • Journal of Clinical Oncology
  • Blood Cancer Journal
  • Transplantation and Cellular Therapy

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

    S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade

  • Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

    Paul G. Richardson;Pieter Sonneveld;Michael W. Schuster;David Irwin

  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

    Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie

  • Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

    Antonio Palumbo;Hervé Avet-Loiseau;Stefania Oliva;Henk M. Lokhorst

  • Initial genome sequencing and analysis of multiple myeloma

    Michael A. Chapman;Michael S. Lawrence;Jonathan J. Keats;Kristian Cibulskis

  • Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

    Nikhil C Munshi;Larry D Anderson;Nina Shah;Deepu Madduri

  • Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

    Donna M. Weber;Christine Chen;Ruben Niesvizky;Michael Wang

  • Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

    Abstr Act;Sagar Lonial;Meletios Dimopoulos;Antonio Palumbo

  • Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

    S. Vincent Rajkumar;Jean Luc Harousseau;Brian Durie;Kenneth C. Anderson

  • Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

    Paul G. Richardson;Edie Weller;Sagar Lonial;Andrzej J. Jakubowiak

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

    Jesús F. San-Miguel;Vânia T.M. Hungria;Sung Soo Yoon;Meral Beksac

  • International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

    A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel

  • Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

    Sagar Lonial;Brendan M Weiss;Saad Z Usmani;Seema Singhal

  • Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the International Myeloma Working Group

    Pieter Sonneveld;Hervé Avet-Loiseau;Sagar Lonial;Saad Usmani

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin

  • Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Richard I. Fisher;Steven H. Bernstein;Brad S. Kahl;Benjamin Djulbegovic

  • Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth

    Taro Hitosugi;Sumin Kang;Matthew G. Vander Heiden;Tae Wook Chung

Frequent Co-Authors

Paul G. Richardson
Paul G. Richardson Harvard University
Lawrence H. Boise
Lawrence H. Boise Emory University
Christopher R. Flowers
Christopher R. Flowers The University of Texas MD Anderson Cancer Center
Robert Z. Orlowski
Robert Z. Orlowski The University of Texas MD Anderson Cancer Center
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Ravi Vij
Ravi Vij Washington University in St. Louis
David S. Siegel
David S. Siegel Hackensack University Medical Center
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Shaji Kumar
Shaji Kumar Mayo Clinic
Saad Z. Usmani
Saad Z. Usmani Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA often opens the door to diverse healthcare career options beyond the traditional MD path. For those eager to enter patient care quickly, a 6 month lpn program online offers a fast-track way to become a Licensed Practical Nurse. This pathway provides hands-on experience and foundational clinical skills.

Nurses with advanced degrees may consider mental health specialties. The shortest post master's pmhnp online programs enable registered nurses to quickly qualify as Psychiatric Mental Health Nurse Practitioners, responding to the growing demand for mental health professionals.

Not all healthcare careers require direct patient care. Students interested in the business and leadership side of medicine can explore healthcare administration degrees that prepare graduates for roles in hospital management and healthcare services.

For those pursuing senior leadership, affordable mha online programs provide the skills needed to oversee complex healthcare organizations, all through flexible online study. These programs make advancing your career more accessible and align with the evolving landscape of U.S. healthcare.

Best Scientists Citing Sagar Lonial

Trending Scientists